Dear colleagues and friends,
It is our pleasure to welcome you to the 2nd conference in the series Recent Advances in Rare Disease – RARD: Frequently Misdiagnosed Hereditary Disorders (FREMIDIS) – Multidisciplinary Translational Research Affects Global Clinical Impact.
Given the complexity of rare diseases, the limited natural history data, and the smaller pool of patients to participate in clinical development, expert exchange is a necessary part towards the future of personalized medicine and orphan drug R&D.
The dedication to help as many rare disease patients lead an as normal life as possible by transforming the worldwide science of genetic, clinical and R&D data into answers drives the conference’s spirit – bringing together international experts, scientists and clinicians to discuss and exchange experiences, current research data and the future development.
The projection for scientific exploration, clinical application and development of new treatments has been proven to be huge especially in the last years.
We would be very pleased to have you participate at this unique networking forum and we are looking forward to many stimulating talks and discussions as well as a great encourage for our future endeavors – having the patient always in the center of all what we do.
SCIENTIFIC ADVISORY COMMITTEE:
- Prof. Mia Horowitz /Israel
- Prof. Anil Jalan /India
- Prof. Elena Lukina /Russia
- Prof. Uma Ramaswami /UK
- Prof. Arndt Rolfs /Germany
- Prof. IC Verma /India
- Prof. Ari Zimran /Israel
RARD 2017 Moscow / Russia
The first meeting of the RARD series took place 18-20 May 2017 in Moscow/Russia with more than 250 participants from around the globe who discussed 3 days about “Recent advances in rare disease: Gaucher disease as a model (RARD 2017)”